Details for Patent: 6,514,980
✉ Email this page to a colleague
Summary for Patent: 6,514,980
Title: | Nucleoside analogs in combination therapy of herpes simplex infections |
Abstract: | A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. |
Inventor(s): | Boyd; Malcolm Richard (Epsom, GB) |
Assignee: | Novartis International Pharmaceutical Ltd. (Hamilton, BM) |
Application Number: | 09/626,015 |
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 6,514,980
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,514,980
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9601544 | Jan 26, 1996 |
International Family Members for US Patent 6,514,980
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 005551 | ⤷ Try a Trial | |||
Austria | 238796 | ⤷ Try a Trial | |||
Australia | 1550697 | ⤷ Try a Trial | |||
Australia | 713202 | ⤷ Try a Trial | |||
Brazil | 9707304 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |